In multivariate analysis with SVR as the outcome variable, unusual genotype 1 remained highly significant with a p value of 0.016 (Chi-Squared: 5.78, df = 1), treatment regimen (NS5A inhibitor-based vs . protease inhibitor) was close to significant with a p value of 0.054 (Chi-Squared: 3.69, df = 1).
← all excerpts
Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.
1
—
—